Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
fda published : Today save search
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
Published: 2024-04-25 (Crawled : 11:00) - globenewswire.com
EYEN | $0.5835 7.54% 7.99% 740K
|
Health Technology
| Email alert
Add to watchlist
update
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer
Published: 2024-04-25 (Crawled : 08:00) - biospace.com/
IBRX | $4.82 -12.2% -14.02% 700K
|
Manufacturing
| Email alert
Add to watchlist
fda anktiva lung positive cancer cell for meeting results
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
Published: 2024-04-25 (Just crawled : 12:00) - globenewswire.com
CMPX | $1.48 -2.63% -2.01% 110K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
ctx-009 fda paclitaxel tumors treatment designation for therapeutics advanced
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.